Clevidipine is a dihydropyridine calcium channel blocker used as an active pharmaceutical ingredient for the reduction of blood pressure when oral therapy is not feasible or not desirable. It is administered intravenously and has a short half-life of approximately one minute, allowing practitioners to titrate the dose to achieve desired blood pressure control.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 167221-71-8
Felodipine
pharmaceutical raw material
Hydroxocobalamin sulfate
pharmaceutical raw material
Belzutifan
pharmaceutical raw material
Tropine benzylate hydrochloride
pharmaceutical raw material
Ornidazole
pharmaceutical raw material
Dimethyl 4-(2-chlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
pharmaceutical raw material
(+/-)-Felodipine (2,3-dichlorophenyl-d3)
pharmaceutical intermediate
3-Desethyl-3-(2-aminoethyl) aminoethoxy Amlodipine
pharmaceutical intermediate
5-O-(butanoyloxymethyl) 3-O-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
KPBZROQVTHLCDU-UHFFFAOYSA-N
CCCC(=O)OCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C